Jaundice Meter Market Size, Share & Trends Analysis Report By Product (Portable, Bench-Top), By Applications (Hospital, Home), By End Use, By Region, and Segment Forecasts - 2035

Jaundice Meter Market Overview

The jaundice meter market was valued at USD 90.52 million in 2025, The market is set to reach USD 92.33 million by 2026-end and grow at a CAGR of 2% between 2026-2035 to reach USD 112.74 million by 2035.

The Jaundice Meter Market is expanding steadily as hospitals, neonatal departments, maternity centers, pediatric clinics, and home-care programs increase attention to early identification and monitoring of neonatal hyperbilirubinemia. Between 2026 and 2035, the market is projected to add approximately USD 20.41 million, representing growth of about 22.11% over the forecast period. Portable devices are estimated to remain the leading product type because clinicians increasingly prefer compact, non-invasive instruments that can be moved between maternity wards, neonatal intensive care units, outpatient departments, and community-care environments. Bench-Top systems continue to serve hospitals and specialized neonatal facilities where fixed-location measurement, standardized testing workflows, and centralized patient screening are preferred. Hospital remains the dominant application because most newborn bilirubin assessment takes place shortly after delivery, during neonatal observation, or through follow-up examinations when elevated bilirubin is suspected. Home applications are gradually gaining relevance as post-discharge monitoring, community pediatric care, and decentralized newborn follow-up expand. Manufacturers are increasingly improving optical sensors, calibration stability, transcutaneous measurement algorithms, skin-contact interfaces, display readability, battery performance, data storage, and portability. The projected 2% CAGR reflects a mature clinical device category supported by continuing births, greater emphasis on newborn screening, demand for non-invasive testing, reduced dependence on repeated blood sampling, and wider use of portable measurement across both advanced and developing healthcare systems.

The U.S. remains an important Jaundice Meter Market because of its established neonatal screening infrastructure, high hospital delivery rate, widespread pediatric follow-up, strong neonatal intensive care capability, and growing focus on reducing avoidable blood sampling in newborns. As the global market increases from USD 92.33 million in 2026 to USD 112.74 million by 2035, U.S. demand is expected to remain supported by maternity hospitals, newborn nurseries, pediatric departments, community health providers, and outpatient follow-up programs. Portable jaundice meters are particularly valuable because newborns may need repeated bilirubin checks during the first days after birth, and rapid non-invasive measurement can support clinical decisions about whether further laboratory testing is required. U.S. healthcare organizations increasingly value devices with fast measurement, straightforward cleaning, reliable calibration, digital records, and easy staff training. Through 2035, the U.S. market is expected to benefit from continued neonatal safety initiatives, early-discharge monitoring, pediatric follow-up, device replacement cycles, and adoption of workflow-friendly instruments that support faster assessment without adding substantial burden to newborn care.

• 

  Download Free sample to learn more about this report.

Key Findings

• Leading Product Type: Portable is estimated to account for approximately 71% of current product demand, supported by bedside use, rapid screening, compact construction, battery operation, mobility between wards, and growing preference for non-invasive neonatal assessment.
• Leading Application: Hospital is estimated to represent approximately 82% of current application demand because most bilirubin screening, newborn observation, phototherapy assessment, and neonatal follow-up are performed through clinical healthcare facilities.
• Leading Region: North America is estimated to hold approximately 35% of current demand, supported by advanced maternity care, neonatal screening protocols, hospital purchasing capacity, device replacement, and high adoption of transcutaneous bilirubin measurement.
• Fastest Growing Region: Asia-Pacific is positioned for strong expansion and currently contributes approximately 31% of global demand as hospital births, neonatal care infrastructure, pediatric screening, and access to portable medical devices increase.
• Technology Trend: Improved optical sensing, automated calibration, digital data storage, rechargeable operation, and faster transcutaneous measurement are improving workflow efficiency, while Bench-Top devices represent approximately 29% of product demand.
• Market Driver: Growing emphasis on early neonatal jaundice identification remains the strongest demand driver, with the overall market projected to expand approximately 22.11% between 2026 and 2035.
• Competitive Landscape: Eight supplied companies compete through optical accuracy, portability, calibration, neonatal workflow integration, product reliability, service support, and distribution as the market adds approximately USD 20.41 million through 2035.
• Future Outlook: Portable screening, digital documentation, community newborn follow-up, home-oriented monitoring, and simplified clinical workflows are expected to strengthen as the market reaches approximately 1.22 times its 2026 size by 2035.

Latest Trends

Portable non-invasive bilirubin measurement is one of the strongest trends shaping the Jaundice Meter Market. Portable devices, estimated to account for approximately 71% of current product demand, increasingly combine compact optical sensors, rechargeable batteries, simplified controls, digital displays, memory functions, and quick measurement cycles. The market's projected expansion of approximately 22.11% between 2026 and 2035 is encouraging manufacturers to improve device ergonomics and clinical usability rather than focusing only on measurement capability. Neonatal nurses and pediatric staff often need to perform multiple assessments during routine observation, so equipment that can be carried easily between newborns improves workflow. Non-invasive transcutaneous measurement can also reduce the need for repeated blood collection when used as an initial screening tool. Manufacturers are refining skin-contact probes, calibration procedures, internal quality checks, and signal-processing algorithms to maintain consistent readings across varying newborn skin conditions. Through 2035, Portable products are expected to remain central to market development as healthcare systems prioritize faster screening and simpler bedside workflows.

Digital integration and post-discharge monitoring represent another important trend. Hospital applications currently represent approximately 82% of demand, but Home applications are gradually gaining attention as newborns are discharged earlier and families return for follow-up bilirubin assessment. Devices capable of storing multiple readings can help clinicians review bilirubin progression over time rather than relying on a single measurement. Digital interfaces and structured data capture can also support integration with neonatal records where available. Home applications, estimated at approximately 18% of current demand, are expected to remain smaller than Hospital use because jaundice interpretation still requires clinical oversight, but decentralized monitoring may expand through pediatric home visits and community-care services. Through 2035, manufacturers are expected to emphasize connectivity, clearer displays, simplified calibration, infection-control-friendly surfaces, and measurement workflows suitable for both institutional and mobile care environments.

Market Dynamics

Driver

""Early neonatal jaundice screening is sustaining demand for rapid and non-invasive bilirubin measurement.""

The strongest driver of the Jaundice Meter Market is growing emphasis on early identification of neonatal hyperbilirubinemia before bilirubin levels become clinically concerning. The market is projected to increase from USD 92.33 million in 2026 to USD 112.74 million by 2035, adding approximately USD 20.41 million during the forecast period. Hospital applications account for approximately 82% of current demand because newborns are commonly evaluated during maternity admission, routine neonatal observation, follow-up visits, and treatment monitoring. Jaundice meters provide clinicians with a rapid estimate of bilirubin concentration through the skin, allowing healthcare teams to determine whether additional laboratory assessment may be appropriate. The ability to screen without immediate blood collection is especially valuable when repeated checks are required during the first several days after birth.

Portable device adoption further strengthens this driver. Portable systems represent approximately 71% of current product demand because clinicians can move them easily between newborn nurseries, maternity wards, pediatric units, and outpatient clinics. Rapid measurement helps reduce time between suspicion of jaundice and initial assessment. The projected 2% CAGR reflects steady rather than explosive growth because jaundice meters are already established in many advanced healthcare environments. Through 2035, continuing improvements in neonatal screening protocols, staff training, and access to portable medical devices are expected to sustain market demand.

Restraint

""Clinical confirmation requirements and measurement variability can limit complete reliance on transcutaneous screening.""

A major restraint is that jaundice meters are primarily screening and monitoring tools rather than universal replacements for laboratory bilirubin testing. Portable devices representing approximately 71% of current demand can provide rapid readings, but clinicians may still require blood-based confirmation when bilirubin values are elevated, inconsistent, or clinically significant. Although the market is projected to grow at a 2% CAGR, dependence on confirmatory testing can limit the extent to which jaundice meters replace existing laboratory workflows. Measurement performance may also be influenced by skin characteristics, device positioning, gestational age, previous phototherapy, or differences between device algorithms, making standardized operating procedures important.

Cost sensitivity creates another restraint. Home applications account for approximately 18% of current demand and remain limited partly because many families cannot justify purchasing dedicated jaundice-monitoring equipment for a short neonatal period. Smaller hospitals and clinics may also delay replacement if existing devices remain functional. Through 2035, manufacturers that improve affordability, calibration stability, durability, and ease of use are expected to reduce these barriers, particularly across emerging healthcare markets and decentralized care settings.

Opportunity

""Community newborn care and portable screening create meaningful opportunities outside major hospital centers.""

Community-based neonatal monitoring provides one of the strongest opportunities in the Jaundice Meter Market. The market is projected to expand approximately 22.11% between 2026 and 2035, creating additional demand for compact devices that can support pediatric clinics, community nursing, maternity follow-up, and home visits. Home applications currently represent approximately 18% of demand and can increase as healthcare systems explore more decentralized newborn monitoring. Portable meters allow healthcare professionals to assess bilirubin without requiring every infant to remain within a hospital environment. This can be particularly useful where newborns are discharged quickly but still require follow-up during the period when jaundice may become more visible.

Asia-Pacific provides another important opportunity and currently represents approximately 31% of global demand. Large birth populations, improving hospital infrastructure, rising awareness of neonatal health, and expansion of private maternity services can increase demand for bilirubin screening devices. Portable instruments are particularly attractive where healthcare providers need to serve multiple wards or facilities with limited equipment budgets. Through 2035, companies that provide affordable systems, local service support, durable designs, straightforward training, and regional distribution are positioned to capture stronger demand.

Challenge

""Maintaining reliable readings across diverse newborn populations remains a key technical challenge.""

The principal technical challenge is maintaining consistent measurement accuracy across newborns with different skin characteristics, gestational ages, bilirubin levels, and clinical conditions. Portable products representing approximately 71% of current demand must perform reliably despite frequent handling and repeated movement between patients. Optical measurement depends on how light interacts with skin and underlying tissue, making calibration and algorithm design critical. Manufacturers therefore need robust sensor design, stable optical components, effective internal calibration, and validation across diverse newborn populations. Infection-control requirements also mean devices must tolerate repeated cleaning without degradation of sensor performance.

Clinical workflow variation creates another challenge. Eight supplied companies compete in a market where hospitals may use different bilirubin screening protocols, laboratory thresholds, follow-up schedules, and phototherapy practices. Bench-Top systems representing approximately 29% of current product demand may fit centralized testing environments, while Portable systems are better suited to decentralized bedside use. Through 2035, manufacturers capable of offering reliable technology alongside clear training, standardized measurement procedures, and strong technical support are expected to achieve stronger adoption.

• 

  Download Free sample to learn more about this report.

Segmentation Analysis

By Types

Portable: Portable jaundice meters are estimated to account for approximately 71% of current Jaundice Meter Market demand and remain the leading product category because bedside screening is a central requirement across maternity wards, neonatal departments, pediatric clinics, and community follow-up programs. The approximately 71% share reflects demand for compact devices that can move between newborns and provide rapid transcutaneous bilirubin estimates without requiring fixed laboratory infrastructure. The market's projected increase from USD 92.33 million in 2026 to USD 112.74 million by 2035 supports continued replacement of older devices with lighter systems offering improved battery life, simplified calibration, clearer displays, digital memory, and more durable optical probes. Portable devices are particularly valuable in hospitals where several maternity and pediatric units share equipment. They can also support community nurses or outpatient practitioners performing post-discharge follow-up. Manufacturers increasingly focus on ergonomic grip, one-handed operation, rapid measurement, rechargeable batteries, and easy cleaning. Through 2035, Portable products are expected to maintain leadership because mobility directly supports the repetitive and distributed nature of neonatal jaundice screening.

Bench-Top: Bench-Top jaundice meters are estimated to represent approximately 29% of current product demand and remain important in hospitals, neonatal departments, pediatric laboratories, and specialized clinical environments where measurements are performed at a defined workstation. The approximately 29% share reflects demand for stable equipment that can be integrated into standardized institutional workflows. Bench-Top systems can provide consistent power availability, centralized calibration, durable construction, and controlled operating conditions. The projected market expansion of approximately 22.11% through 2035 creates continued demand for improved displays, digital records, easier calibration, and simplified maintenance. Bench-Top equipment can be particularly useful when neonatal screening is concentrated within one department rather than distributed throughout a large hospital. Through 2035, this category is expected to remain a meaningful secondary segment serving institutions that prioritize centralized operation and controlled device management.

By Applications

Hospital: Hospital is estimated to account for approximately 82% of current Jaundice Meter Market demand and remains the dominant application because newborn bilirubin screening is closely linked with maternity care, neonatal observation, pediatric assessment, phototherapy monitoring, and follow-up after delivery. The approximately 82% share reflects extensive use across maternity hospitals, neonatal intensive care units, pediatric wards, birthing centers, and outpatient departments connected with hospital networks. The market's projected addition of approximately USD 20.41 million between 2026 and 2035 supports continuing replacement and expansion of jaundice meter fleets. Hospitals increasingly seek non-invasive screening methods that reduce the number of unnecessary blood draws while supporting rapid identification of newborns needing additional evaluation. Portable devices allow staff to measure infants at the bedside, while Bench-Top systems support centralized workflows. Through 2035, Hospital is expected to remain the leading application because most clinical decisions around significant neonatal jaundice continue to be managed within professional healthcare environments.

Home: Home applications are estimated to represent approximately 18% of current market demand and provide a smaller but developing opportunity through community nursing, pediatric follow-up, home healthcare, and post-discharge newborn monitoring. The approximately 18% share reflects growing interest in checking bilirubin outside conventional hospital environments while maintaining clinical oversight. Portable jaundice meters are most suitable for this application because they can be transported easily by healthcare professionals. As the market reaches USD 112.74 million by 2035, Home applications are expected to benefit from earlier hospital discharge, expansion of pediatric home visits, and increased emphasis on follow-up during the first days after birth. Through 2035, growth will depend on affordability, simple operation, clinical supervision, reliable calibration, and clear processes for escalating elevated measurements to professional medical assessment.

• 

  Download Free sampleto learn more about this report.

Regional Outlook

North America

North America is estimated to account for approximately 35% of current Jaundice Meter Market demand and maintains a leading position through advanced maternity care, broad neonatal screening practices, strong hospital purchasing capability, established pediatric follow-up, and high availability of non-invasive diagnostic devices. The United States contributes the majority of regional demand, while Canada supports additional adoption through hospital-based neonatal programs and community care. The approximately 35% regional position reflects strong acceptance of transcutaneous bilirubin measurement as part of newborn assessment workflows.

Device replacement and digital integration provide additional regional momentum. The approximately 35% position creates demand for modern Portable systems with longer battery life, clearer displays, digital storage, improved calibration, and simplified infection-control procedures. Hospitals increasingly seek instruments that can be shared across several maternity and neonatal units without requiring extensive staff retraining. As the global market reaches USD 112.74 million by 2035, North America is expected to remain an important premium market. Suppliers offering reliable clinical performance, strong after-sales support, and workflow-friendly designs are positioned competitively.

Europe

Europe is estimated to account for approximately 24% of current Jaundice Meter Market demand and is supported by mature maternity services, standardized neonatal care, pediatric follow-up, universal healthcare coverage in many markets, and strong emphasis on reducing unnecessary invasive procedures. Germany, the United Kingdom, France, Italy, Spain, Nordic countries, and other European markets contribute through both hospital and community newborn-care programs. The approximately 24% regional position reflects established use of non-invasive bilirubin screening within structured neonatal pathways.

Community care provides additional regional momentum. The approximately 24% position creates demand for Portable devices that can support midwives, neonatal nurses, outpatient clinics, and post-discharge follow-up. Healthcare systems increasingly seek to avoid unnecessary hospital readmissions while ensuring that newborns with rising bilirubin receive timely reassessment. As the global market advances toward USD 112.74 million by 2035, Europe is expected to remain an important market for reliable and clinically integrated devices. Suppliers emphasizing accuracy, ease of cleaning, digital records, and user-friendly operation are positioned to maintain adoption.

Asia-Pacific

Asia-Pacific is estimated to represent approximately 31% of current Jaundice Meter Market demand and is positioned for strong expansion through large newborn populations, hospital construction, improving maternity services, growing neonatal-care awareness, and wider availability of portable medical devices. China contributes significantly through hospital and pediatric-care expansion, while Japan and South Korea support technologically advanced neonatal screening. India and Southeast Asia provide additional growth potential as institutional deliveries and private maternity services increase. The approximately 31% regional position reflects both large patient volumes and uneven access to modern screening technology.

Portable equipment provides additional regional momentum. The approximately 31% position creates opportunities for devices that can serve several wards, outpatient clinics, and community-care programs without requiring substantial fixed infrastructure. Price remains an important consideration, increasing demand for durable systems with low operating complexity. As the global market expands approximately 22.11% through 2035, Asia-Pacific is expected to capture meaningful incremental demand. Manufacturers providing local distribution, service, affordable calibration, and clinician training are positioned to strengthen regional penetration.

Middle East & Africa

Middle East & Africa is estimated to represent approximately 10% of current Jaundice Meter Market demand and provides developing opportunities through maternity hospital expansion, private healthcare investment, neonatal-care programs, pediatric services, and greater awareness of early jaundice identification. Gulf countries contribute through advanced private and public hospital systems, while South Africa, North Africa, and selected developing markets provide additional demand. The approximately 10% regional position remains smaller than other major regions but offers meaningful long-term potential as neonatal screening infrastructure improves.

Healthcare access expansion provides additional regional momentum. The approximately 10% current position creates opportunities for rugged Portable jaundice meters that can be used across hospitals, maternity clinics, and outreach environments. Equipment durability, battery life, calibration simplicity, and local technical support are particularly important where specialized biomedical service may be limited. As the global market grows at a projected 2% CAGR through 2035, Middle East & Africa is expected to contribute incremental demand through hospital modernization, improving newborn care, and wider adoption of non-invasive screening technologies.

List of Top Jaundice Meter Companies

• Dräger
• Delta Medical International
• Xuzhou Kejian Hi-tech
• Aegis Medicals
• Natus Medical
• Refine Medical Technology
• M&B
• Micro Lab

Top 2 Companies Market Share

Dräger: Dräger is estimated to account for approximately 19% of competitive Jaundice Meter Market demand, supported by established neonatal-care expertise, strong hospital relationships, medical-device engineering, clinical support, distribution, and recognition across maternity and newborn-care environments. Its competitive position aligns closely with Hospital applications, which represent approximately 82% of current market demand. The projected 2% CAGR provides continued opportunities for Portable jaundice meters, neonatal workflow integration, improved calibration, digital records, and device replacement. Continued investment in clinical usability, reliability, and technical support can reinforce its market position through 2035.

Natus Medical: Natus Medical is estimated to represent approximately 16% of competitive demand, supported by specialization in neonatal and pediatric technologies, established relationships with newborn-care departments, clinical workflow expertise, and broad presence across healthcare institutions. Its position benefits from Portable devices, which account for approximately 71% of current product demand. The projected market expansion of approximately USD 20.41 million between 2026 and 2035 creates opportunities for non-invasive bilirubin screening, improved device portability, digital documentation, and neonatal follow-up workflows. Continued emphasis on newborn-focused product design can strengthen competitiveness.

Investment Analysis

Investment in the Jaundice Meter Market is increasingly focused on optical sensor quality, calibration technology, rechargeable batteries, compact electronics, digital memory, ergonomic housings, connectivity, infection-control-friendly surfaces, automated quality checks, and clinical software integration. The market is projected to rise from USD 92.33 million in 2026 to USD 112.74 million by 2035, creating approximately USD 20.41 million in additional market scale. Manufacturers can improve device value by investing in optical systems that maintain stable readings across repeated use while minimizing calibration burden. Battery technology is particularly important for Portable devices because clinical users require dependable operation throughout maternity and neonatal shifts. Improved displays and simplified interfaces can reduce staff training time, while durable external materials can withstand frequent disinfection. Digital memory can help clinicians review previous measurements and identify changes in bilirubin trends during follow-up.

Emerging healthcare markets provide another important investment opportunity. Asia-Pacific represents approximately 31% of current global demand and combines large newborn populations with continuing expansion of maternity and neonatal services. Companies can invest in local assembly, service centers, distributor training, calibration support, and affordable device configurations. Hospital demand at approximately 82% remains the largest opportunity, but Home-oriented applications can create incremental demand through community pediatric programs. Through 2035, suppliers combining clinical reliability with affordable lifecycle costs and strong regional service are expected to achieve stronger competitive positioning.

New Product Development

New product development in the Jaundice Meter Market increasingly focuses on lighter Portable devices, faster measurements, improved optical algorithms, rechargeable operation, automated calibration checks, simplified cleaning, clearer displays, and digital storage. Portable products representing approximately 71% of current product demand provide the largest platform for innovation because neonatal clinicians increasingly prioritize bedside mobility and rapid repeated screening. Manufacturers are developing devices that require fewer operating steps and provide immediate visual confirmation that measurements have been captured successfully. As the market reaches USD 112.74 million by 2035, new products are expected to emphasize consistent clinical performance, durability, ease of use, and greater compatibility with electronic documentation workflows.

Bench-Top products representing approximately 29% of current demand provide additional opportunities through larger displays, centralized patient data, improved calibration management, and integration with neonatal department workflows. Home applications at approximately 18% can also support development of simplified portable platforms intended for professional community care rather than unsupervised interpretation. Through 2035, successful products are expected to combine accurate transcutaneous measurement, ergonomic design, reliable battery performance, straightforward calibration, digital records, and flexible operation across hospital, outpatient, and community newborn-care environments.

Five Recent Developments

• February 2024: Jaundice meter development increasingly emphasized compact rechargeable designs as neonatal departments sought devices that could move easily between maternity wards, nurseries, and outpatient follow-up settings.
• August 2024: Automated calibration checks gained stronger development focus as manufacturers worked to simplify clinical operation and improve confidence in repeated transcutaneous bilirubin measurements.
• March 2025: Digital measurement storage gained wider attention as hospitals increasingly sought better documentation of bilirubin trends across repeated neonatal assessments and post-discharge follow-up.
• October 2025: Improved optical sensing and ergonomic probe designs gained momentum as manufacturers prioritized faster measurement, easier newborn positioning, and more consistent bedside workflows.
• June 2026: Portable screening, rechargeable operation, digital records, simplified calibration, and community neonatal monitoring gained further momentum as the market entered a forecast period characterized by a 2% CAGR.

Report Coverage

The Jaundice Meter Market assessment covers Portable and Bench-Top products across Hospital and Home applications. The market was valued at USD 90.52 million in 2025 and is projected to increase from USD 92.33 million in 2026 to USD 112.74 million by 2035 at a CAGR of 2%. Portable is estimated to account for approximately 71% of current product demand, while Bench-Top represents approximately 29%. Hospital accounts for approximately 82% of current application demand, while Home represents approximately 18%. The assessment examines transcutaneous bilirubin measurement, optical sensing, neonatal jaundice screening, device portability, calibration, digital records, battery performance, clinical workflow, newborn follow-up, community care, hospital screening, infection control, device replacement, and non-invasive neonatal assessment.

The competitive assessment includes Dräger, Delta Medical International, Xuzhou Kejian Hi-tech, Aegis Medicals, Natus Medical, Refine Medical Technology, M&B, and Micro Lab. Competitive positioning is evaluated through measurement reliability, optical technology, portability, calibration stability, neonatal workflow integration, clinical support, distribution, service availability, and device durability. North America is assessed through advanced neonatal screening, maternity infrastructure, pediatric follow-up, device replacement, and hospital purchasing capacity, Asia-Pacific through large newborn populations, expanding hospital care, maternity investment, and rising screening awareness, Europe through mature neonatal care, community follow-up, structured pediatric pathways, and non-invasive screening adoption, and Middle East & Africa through maternity expansion, healthcare modernization, newborn-care investment, and improving access to portable diagnostic technology. Investment priorities include optical sensing, battery systems, calibration, digital memory, ergonomic design, clinical software integration, and regional service. Product development increasingly emphasizes compact portable platforms, faster measurement, automated quality checks, simpler cleaning, reliable calibration, digital documentation, and jaundice meters designed for increasingly flexible neonatal screening environments.